
NHP iPSC-Derived vCMs for in vitro Safety and Toxicity Screening

In Vitro ADC Safety Profiling with an iPSC-Derived Human Tissue Screen

Automated 3D iPSC Cardiac Microtissues for Calcium Transient Screening

Human iPSC platform for ASO efficacy and CNS safety screening

Development of robust iPSC-based α-Synuclein, Tau and TDP-43 aggregation models for drug discovery

A human scalable platform for high-throughput screening of drug candidates targeting pathological aggregation of TAU, αSynuclein and TDP-43
